Evidence map›Paper›PMID 36722508›Full record

ReviewNanoscale2023

Uptake and stability of DNA nanostructures in cells: a cross-sectional overview of the current state of the art.

Divita Mathur, Angelica Rose Galvan, Christopher M Green, Kevin Liu, Igor L Medintz

Open access · greenAbstract readReview
In one paragraph

Review in Nanoscale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Traction Force Microscopy with DNA FluoroCubes.Langmuir : the ACS journal of surfaces and colloids · 2026
    Article
  3. Article
  4. Review
  5. DNA Origami-Cyanine Nanocomplex for Precision Imaging of KRAS-Mutant Pancreatic Cancer Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. The role of size in biostability of DNA tetrahedra.Chemical communications (Cambridge, England) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Divita MathurDepartment of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA. divita.mathur@case.edu.ORCID http://orcid.org/0000-0002-3537-7292
Angelica Rose GalvanFischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.ORCID http://orcid.org/0000-0002-7616-4760
Christopher M GreenCenter for Bio/Molecular Science and Engineering, Code 6900, US Naval Research Laboratory, Washington, DC 20375, USA.ORCID http://orcid.org/0000-0001-7848-7144
Kevin LiuDepartment of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA. divita.mathur@case.edu.ORCID http://orcid.org/0000-0003-1014-6807
Igor L MedintzCenter for Bio/Molecular Science and Engineering, Code 6900, US Naval Research Laboratory, Washington, DC 20375, USA.ORCID http://orcid.org/0000-0002-8902-4687
United States Naval Research Laboratory · USCase Western Reserve University · US

Funding

Cytosolic Access and Instability of DNA nanoparticlesR00EB030013 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI MATHUR, DIVITA · 2022 to 2024
$747k
NIBIB NIH HHS R00 EB030013
6 · The paper itself

Abstract

The physical and chemical properties of synthetic DNA have transformed this prototypical biopolymer into a versatile nanoscale building block material in the form of DNA nanotechnology. DNA nanotechnology is, in turn, providing unprecedented precision bioengineering for numerous biomedical applications at the nanoscale including next generation immune-modulatory materials, vectors for targeted delivery of nucleic acids, drugs, and contrast agents, intelligent sensors for diagnostics, and theranostics, which combines several of these functionalities into a single construct. Assembling a DNA nanostructure to be programmed with a specific number of targeting moieties on its surface to imbue it with concomitant cellular uptake and retention capabilities along with carrying a specific therapeutic dose is now eminently feasible due to the extraordinary self-assembling properties and high formation efficiency of these materials. However, what remains still only partially addressed is how exactly this class of materials is taken up into cells in both the native state and as targeted or chemically facilitated, along with how stable they are inside the cellular cytosol and other cellular organelles. In this minireview, we summarize what is currently reported in the literature about how (i) DNA nanostructures are taken up into cells along with (ii) what is understood about their subsequent stability in the complex multi-organelle environment of the cellular milieu along with biological fluids in general. This allows us to highlight the many challenges that still remain to overcome in understanding DNA nanostructure-cellular interactions in order to fully translate these exciting new materials.

Indexed as

NanostructuresCross-Sectional StudiesDNANanotechnologyPharmaceutical PreparationsDNAPharmaceutical Preparations

Identifiers

PMID36722508
PMCPMC10407680
OpenAlexW4317934240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.